Global Fluorescence Guided Surgery Systems Market 2023-2029

February 2023 | 84 pages | ID: GA392C1497E3EN
Gen Consulting Company

Abstracts

Fluorescence-guided technology is a lifesaving imaging tool that lights up tumors and cancer cells as well as nerves and other anatomical features for easier identification and precise removal or preservation during surgeries. This approach is changing how surgery can be performed more safely and accurately for patients. According to Gen Consulting Company, the global fluorescence guided surgery systems market is set to achieve an incremental growth of USD 108.6 million, accelerating at a CAGR of almost 12.5% during the forecast period 2023-2029.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global fluorescence guided surgery systems market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, surgery, application, and region. The global market for fluorescence guided surgery systems can be segmented by product: SPY system, VS3 iridium system, PDE system, others. The SPY system segment captured the largest share of the market in 2022. Fluorescence guided surgery systems market is further segmented by surgery: laparoscopy/endoscopy, open surgery. The laparoscopy and endoscopy segment held the largest share of the global fluorescence guided surgery systems market in 2022 and is anticipated to hold its share during the forecast period. Based on application, the fluorescence guided surgery systems market is segmented into: cancer, cardiovascular diseases, others. In 2022, the cancer segment made up the largest share of revenue generated by the fluorescence guided surgery systems market. On the basis of region, the fluorescence guided surgery systems market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. Among these, North America was accounted for the highest revenue generator in 2022.

Market Segmentation
By product: SPY system, VS3 iridium system, PDE system, others
By surgery: laparoscopy/endoscopy, open surgery
By application: cancer, cardiovascular diseases, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report also provides a detailed analysis of several leading fluorescence guided surgery systems market vendors that include Carl Zeiss AG, Curadel, LLC, Diagnostic Green GmbH, Getinge AB (FLUOPTICS SAS), Hamamatsu Photonics K.K., Intuitive Surgical, Inc., Irillic Pvt. Ltd., KARL STORZ SE & Co. KG, Leica Microsystems GmbH (Danaher Corporation), LI-COR, Inc., Medtronic plc (Visionsense Ltd.), MIZUHO Corporation, Olympus Corporation (Quest Photonic Devices B.V.), OnLume Inc., PerkinElmer, Inc., Shimadzu Corporation, Stryker Corporation (NOVADAQ Technologies Inc.), SurgiMab S.A.S, SurgVision GmbH (Bracco S.p.A.), among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report
To analyze and forecast the market size of the global fluorescence guided surgery systems market.
To classify and forecast the global fluorescence guided surgery systems market based on product, surgery, application, region.
To identify drivers and challenges for the global fluorescence guided surgery systems market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global fluorescence guided surgery systems market.
To identify and analyze the profile of leading players operating in the global fluorescence guided surgery systems market.

Why Choose This Report
Gain a reliable outlook of the global fluorescence guided surgery systems market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints

PART 5. MARKET BREAKDOWN BY PRODUCT

SPY system
VS3 iridium system
PDE system
Others

PART 6. MARKET BREAKDOWN BY SURGERY

Laparoscopy/endoscopy
Open surgery

PART 7. MARKET BREAKDOWN BY APPLICATION

Cancer
Cardiovascular diseases
Others

PART 8. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America

PART 9. KEY COMPANIES

Carl Zeiss AG
Curadel, LLC
Diagnostic Green GmbH
Getinge AB (FLUOPTICS SAS)
Hamamatsu Photonics K.K.
Intuitive Surgical, Inc.
Irillic Pvt. Ltd.
KARL STORZ SE & Co. KG
Leica Microsystems GmbH (Danaher Corporation)
LI-COR, Inc.
Medtronic plc (Visionsense Ltd.)
MIZUHO Corporation
Olympus Corporation (Quest Photonic Devices B.V.)
OnLume Inc.
PerkinElmer, Inc.
Shimadzu Corporation
Stryker Corporation (NOVADAQ Technologies Inc.)
SurgiMab S.A.S
SurgVision GmbH (Bracco S.p.A.)
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER